top of page

it's where dermatology lives

DERM. CITY 2 copy.png

Search

Combination dupilumab, abrocitinib effective in treating refractory pediatric AD

Nov 6, 20241 min read

According to a recent study, a combination of dupilumab and abrocitinib is effective in treating refractory atopic dermatitis (AD) in pediatric patients.

Recent Posts

VIDEO: Inflammation may be linked to stomach problems in psoriasis patients

Chronic hand eczema affects 4.7% of adults in Europe and Canada, study finds

Survey findings: How AD patients define topical steroid withdrawal

Comments

bottom of page